Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- Bevacizumab/interferon-alpha2a provides a progression-free survival benefit in all prespecified patient subgroups as first-line treatment of metastatic renal cell carcinoma (AVOREN)
- Efficacy and safety of first-line bevacizumab (Bv) and cisplatin/gemcitabine (CG) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC) in the BO17704 study (AVAiL)
- Efficacy and safety results from BO17704, a randomised, placebo-controlled phase III study of bevacizumab in combination with cisplatin and gemcitabine in patients with advanced or recurrent non-squamous nonsmall cell lung cancer (NSCLC)
- First-line bevacizumab improves progression-free survival with lower doses of interferon[alpha]2a in the treatment of patients with metastatic renal cell carcinoma (AVOREN)
- Management of hypertension (HTN) in patients with advanced or recurrent non-squamous nonsmall cell lung cancer (NSCLC) receiving first-line cisplatin and gemcitabine with bevacizumab or placebo - results from randomised phase III trial BO17704
- Results for progression-free survival (PFS) from two randomised, double-blind, multicentre phase III studies of bevacizumab in combination with platin-based chemotherapy in patients with advanced or recurrent non-squamous nonsmall cell lung cancer (N
- Subgroup results from a randomised, double-blind, multicentre phase III study of bevacizumab in combination with cisplatin-gemcitabine in chemotherapy-naive patients with advanced or recurrent non-squamous nonsmall cell lung cancer (NSCLC): study BO1
